This is the authors' abstract. We don't add key points for this paper.
Costly and onerous treatment as well as resistance to drugs and pesticides are major challenges to the ambitious goal of eliminating visceral leishmaniasis. However, Dr Robert Killick-Kendrick is optimistic about recent advances in treatment and control.
No takes yet. Share an insight, caveat, or question.
R. Killick‐Kendrick (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: